AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

The past 3 decades have been characterized by an exponential growth in knowledge and
advances in the clinical treatment of atrial fibrillation (AF). It is now known that AF genesis …

Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

During the past decade, catheter ablation of atrial fibrillation (AF) has evolved rapidly from
an investigational procedure to its current status as a commonly performed ablation …

Objectives: The aim of this study was to examine the effect of continuous positive airway
pressure (CPAP) therapy on atrial fibrillation (AF) recurrence in patients with obstructive …

1.1. Organization of Committee and Evidence Review (UPDATED) For new or updated text,
view the 2011 Focused Update and the 2011 Update on Dabigatran. Text supporting …

The present guidelines are a revision of the 2008 version of Guidelines for
Pharmacotherapy of Atrial Fibrillation, 1 which were originally published in 2001, 2 and …

Background—Ablation of atrial fibrillation (AF) is an established treatment option for
symptomatic patients. It is not known whether complete pulmonary vein isolation (PVI) is …

Atrial fibrillation (AF) is the most common sustained cardiac rhythm disturbance, increasing
in prevalence with age. AF is often associated with structural heart disease, although a …

Background—The mainstay of treatment for atrial fibrillation (AF) remains pharmacological;
however, catheter ablation has increasingly been used over the last decade. The relative …